To examine the cellular mechanisms of contractile dysfunction in postinfarction heart failure, we studied the effects of .3-adrenergic receptor stimulation on contractile function and Ca2'i handling of noninfarcted papillary muscles from sham-operated (n=17) and infarcted (n=17) rats. Ca'2+ transients measured with the bioluminescent protein aequorin and parameters of isometric contraction were recorded during graded isoproterenol stimulation. Developed tension and peak rate of tension rise were depressed (p<0.05) in muscles from infarcted rats at physiological and maximally stimulating [Ca21]0s.
T he cellular mechanisms responsible for contractile dysfunction in congestive heart failure have not been clearly elucidated. Because of the importance of calcium in modulating excitation-contraction coupling in the myocyte, there has been much interest in the factors that regulate intracellular handling of free ionized calcium (Ca24i) in different disease states. In this regard, many investigators have focused tropic response to ,3-adrenergic receptor stimulation is blunted in the setting of heart failure.' However, recent studies have suggested that the changes in ,8-adrenergic function may be specific to the etiology of heart failure, i.e., ischemic versus idiopathic.2 Unfortunately, studies using human myocardial tissue obtained at the time of cardiac transplantation are frequently complicated by the pretransplant use of inotropic, anti-ischemic, and vasodilator therapy. These pharmacological agents could alter the results of subsequent in vitro studies. Importantly, previous work has suggested that chronic angiotensin converting enzyme (ACE) inhibition may be associated with upregulation of ,3-adrenoceptors in the setting of heart failure. 3, 4 It is widely appreciated that vasodilator therapy in general, and chronic ACE inhibition in particular, may improve survival in patients with heart failure of various etiologies.5-7 Based on this knowledge, it is no longer considered ethical to withhold vasodilator therapy from patients with established heart failure in clinical trials.7
Therefore, to help clarify the mechanisms whereby ACE inhibition improves clinical status and long-term survival in heart failure, it is necessary to study an animal model. Large myocardial infarction in rats results in marked impairment of global left ventricular (LV) and myocardial function.8 10 Some of these abnormalities appear to be corrected, at least in part, by chronic treatment with ACE inhibitors.8-10 Because ischemic heart disease is the leading cause of heart failure in most large clinical trials,67 we felt that the rat with chronic myocardial infarction was a particularly appropriate model to study.
The current study was designed to test the hypothesis that postinfarction heart failure may be related to abnormalities of excitation-contraction coupling and 13-adrenergic responsiveness in surviving myocardium.
In addition, we speculated that enhanced Ca2`i regulation and inotropic responsiveness to 18-adrenoceptor stimulation in the noninfarcted LV myocardium might contribute to the beneficial effects of chronic ACE inhibition in heart failure.
Materials and Methods
Male Sprague-Dawley rats weighing 220-250 g (Harlan Sprague Dawley, Inc., Indianapolis, Ind.) were used for all studies. All rats were housed two per cage on a 12-hour light/dark cycle and allowed free access to standard rat chow and water. All animals were cared for according to the guidelines of the American Physiological Society. Production of Myocardial Infarction A left anterior thoracotomy was performed under ether anesthesia. The heart was expressed through the incision, and a 6-0 silk ligature was snugly secured around the proximal left coronary artery. The lungs were inflated, and the muscle layer and the skin were separately closed.
Captopril Treatment
One week after surgery, rats were screened for the presence of a large myocardial infarction using ninelead surface electrocardiographic recording." Rats meeting criteria for a large myocardial infarction were randomized to no treatment (n= 17) or treatment with 2 g/l captopril (compliments of E.R. Squibb & Sons, Inc., Princeton, N.J.) in the drinking water (n = 14).810 Captopril was freshly prepared every other day and was administered until the time of the studies described below.
Hemodynamic Measurements
Six weeks after myocardial infarction or sham surgery, rats were lightly anesthetized with ether. The right carotid artery was isolated by cutdown and cannulated with a 1-mm micromanometer-tipped catheter (Millar Instruments, Houston, Tex.), which was retrogradely passed across the aortic valve under constant pressure monitoring. LV systolic and diastolic pressures were recorded. The signal was passed through an electronic differentiator, and dP/dt was simultaneously measured.
Isometric Muscle Performance
Immediately after hemodynamic measurements, the heart was rapidly excised. The noninfarcted LV posterior papillary muscle was dissected free in an oxygen-ated dissecting chamber, and the muscular end was grasped with a spring clip. All muscles were grossly noninfarcted and could be clearly distinguished from the adjacent scar tissue of the LV anterior wall. Previous studies have shown that these muscles are not histologically infarcted. 10 The tendinous end of the muscle was tied to a 6-0 silk suture and vertically suspended from an isometric force transducer (model MBL 341, Sensotec Inc., Columbus, Ohio). The muscle was placed in a 50-ml tissue bath containing modified Krebs-Henseleit solution with the following composition (mM): NaCl 120, KCl 5.9, dextrose 5.5, NaHCO3 25, NaH2P04 1.2, MgCl2 1.2, and CaCl2 1.0. The bath was maintained at a constant temperature of 30°C and bubbled with 95% 02-5% C02. The muscle was stimulated to contract isometrically at 0.33 Hz using a punctate platinum electrode at the base of the muscle. Five-millisecond square-wave pulses were delivered at a voltage approximately 10% above threshold. The muscle was stretched to the length at which maximum tension development occurred and allowed to stabilize for 1 hour. All measurements were made at this length. Baseline measurements were performed before loading of aequorin.
Aequorin Signal Measurements
Aequorin (purchased from Dr. John R. Blinks, Friday Harbor, Wash.) was loaded using a previously described technique.12 Briefly, the calcium concentration of the bath was lowered to approximately 0.1 mM. After the developed tension declined to 50% of its original value, stimulation was stopped, the muscle was briefly raised from the bath, and 1-2 j,l aequorin was injected under the epimysium at the base of the muscle using a shortshank glass micropipette. The muscle was then quickly returned to the bath. To prevent calcium paradox, calcium was gradually reintroduced to the bath until a concentration of 1 mM was reached. After a 1-hour stabilization period, the aequorin signal was measured using a light-collecting apparatus designed by Dr. John R. Blinks and was simultaneously recorded with isometric tension on a physiological recorder (Gould Instruments, Cleveland, Ohio). Analog signals from the force transducer and the photon counter (model C10, Thorn EMI Gencom Inc., Fairfield, N.J.) were also stored on videotape (JVC model 420 H, A.R. Vetter Co., Rebersburg, Pa.). To improve the signal-to-noise ratio, the data from 40-80 steady-state light signals and isometric twitches were averaged (No. 4562, Nicolet Instrument Corp., Madison, Wis.).
Calcium and Isoproterenol Dose-Response Determinations
After baseline measurements were completed, aequorin signals and isometric tension were recorded at [Ca2+]O of 0.25, 0.5, 1.0, 2.0, and 3.0 mM. Phosphate was removed from the bath during the calcium dose-response determination to avoid the possibility of precipitation at higher [Ca 2].. Measurements were made approximately 10 minutes after each change of [Ca`2+].
The bath solution was then replaced with modified Krebs-Henseleit solution containing 1.0 mM Ca`+. Isoproterenol bitartrate (Sigma Chemical Co., St. Louis, Mo.) was dissolved in distilled water and added to the bath to produce cumulative concentrations of 10'9-10`6 M. Light signals and isometric contractions were measured 5 minutes after each addition of isoproterenol or as soon as the response had reached a stable baseline.
Steady-state Force-Cai2+ Relations
Because it is difficult to determine myofilament responsiveness to Ca2' in twitching muscles, we measured steady-state force-Ca'i relations in a subset of muscles from sham-operated (n=5), untreated infarcted (n=4), and captopril-treated infarcted (n=4) rats by a modification of previously described methods.13 Briefly, after washout of isoproterenol for 1 hour, 10-7 M ryanodine was added to the bath. This caused a marked decrease in the amplitude of the isometric twitch and the Ca2' transient. When these parameters were stable (1 hour), tetani were induced by 4 seconds of stimulation at 15 Hz with 50-msec square-wave pulses using field electrodes.
Tetani were induced at [Ca2`]0 of 2.0, 4.0, and 8.0 mM.
Preliminary experiments suggested that there was no further increase in tetanic force at higher [Ca21]o. Force and light were measured at the end of the 4-second tetanus (Figure 7 ). Ca2+i during tetani was calculated using the method of fractional luminescence as described below.
Quantitation of Ca2+
[Ca2+]i was estimated by normalizing the light signal 
Measurement of Infarct Size
After the papillary muscle was removed, the heart was divided into right ventricle and left ventricle plus septum and weighed. The left ventricle was fixed in a buffered 10% formalin solution, cut into four transverse slices, and processed for histology. Sections from each of the four levels were stained with Masson's trichrome.
The sections were projected, and the length of endocardial and epicardial surface involved with the infarction was determined and expressed as a percent of the total LV perimeter.
Analysis
Results are expressed as mean±SEM. Hemodynamic measurements and parameters defining the time course and amplitude of the light signal and the isometric contractions at each concentration of calcium or isoproterenol were compared using one-way analysis of variance. A Student-Newman-Keuls test was then used to test for differences between the three groups where appropriate. For clarity, comparisons of sham versus captopril-treated infarcted groups are not shown. Linear regression was performed using the method of least squares. A value of p<0.05 was considered significant. 
Results
Surgical mortality was 40-50% in the first 48 hours in rats with large infarctions. Mortality in sham-operated rats was <5%. No rats died after randomization to captopril or placebo at 1 week after infarction. Table 1 shows body weights, chamber weights, and infarct size for each of the three groups of rats. Rats in the two infarcted groups gained less weight than the shamoperated rats. LV weight indexed to body weight (BW) was similar in the sham-operated and untreated infarcted rats. LV/BW was decreased by captopril treatment. Untreated infarcted rats developed right ventricular (RV) hypertrophy as defined by RV/BW. This response was attenuated in the captopril-treated infarcted rats. Infarct size was similar in the treated and untreated rats. Papillary muscle cross-sectional areas were not different between the sham-operated (0.85+±0.04 mm2), infarcted (0.98±0.09 mm2), and captopril-treated infarcted (0.83+±0.07 mm2) rats. MI, untreated rats with myocardial infarction; MI Capto, captopril-treated rats with myocardial infarction; HR, heart rate; bpm, beats per minute; MAP, mean arterial pressure; LVSP, left ventricular systolic pressure; LVEDP, left ventricular end-diastolic pressure; +dP/dt, peak rate of left ventricular pressure rise; -dP/dt, peak rate of left ventricular pressure fall. Values are mean±SEM. Comparisons of sham-operated vs. MI Capto rats are not shown. *p<0.05 vs. sham-operated rats. tp<0.05 vs. MI rats. 
85±0.04 0.86±0.04 MI, untreated rats with myocardial infarction; MI Capto, captopril-treated rats with myocardial infarction; DT, developed tension; +dT/dt, peak rate of tension rise; -dT/dt, peak rate of tension fall; TPT, time to peak tension; T1/2R, time to 50% decline in tension from peak tension; TPL, time to peak light; T1/2L, time to 50% decline in light from peak light. Values are mean±SEM. treatment lowered LV systolic pressure, mean arterial pressure, and LV end-diastolic pressure. Heart rate was similar in the three groups of rats.
After aequorin loading, developed tension decreased 17%, 5%, and 15%, while the rate of tension rise (dT/dt) decreased 8%, increased 5%, and decreased 4% compared with baseline values for sham-operated, infarcted, and captopril-treated infarcted rats, respectively (p=NS). Table 3 shows indexes of isometric contractile function in each of the groups measured after aequorin loading. Under these conditions (temperature, 30WC; [Ca2+]0, 1.0 mM; stimulation frequency, 0.33 Hz), papillary muscles from infarcted rats had decreased developed tension, peak positive and negative dT/dt, and prolonged time to peak tension compared with sham-operated rats. Compared with the untreated infarcted rats, muscles from captopril-treated infarcted rats showed improved developed tension and a trend toward improved peak dT/dt but no change in time to peak tension or half time to relaxation.
The time course and amplitude of the Ca2 i transients as determined from the aequorin light signal from each group are shown in Table 3 . Time to peak light and time from peak light to 50% decline in light were prolonged in muscles from the infarcted rats compared with the sham-operated rats. Captopril treatment resulted in normalization of the time to peak light and partial improvement of time from peak light to 50% decline in light. There was no difference in peak Ca2`i availability under baseline conditions among the three groups.
Inotropic responses to increasing [Ca 2+]1 for each group are displayed in Figure 1 . Muscles from all three groups of rats increased developed tension in response to increased Ca 2+1 in a concentration-dependent fashion. However, the concentration-response curve for the untreated infarcted rats was shifted downward (p<0.05) at all [Ca 2+]0s except 0.25 mM compared with the sham rats. The developed tension versus [Ca2+]. developed tension returned to baseline in the muscles from untreated infarcted and captopril-treated infarcted rats but declined moderately in the muscles from the sham-operated rats. Compared with baseline, there was minimal change in dT/dt for any of the three groups after washout of the 3.0 mM [Ca'2+].
The inotropic responses to isoproterenol for all three groups are shown in Figure 2 . Graded isoproterenol stimulation resulted in significant increases in contractility (dT/dt) in muscles from sham-operated rats, whereas this response was markedly attenuated (p<0.05 at all isoproterenol concentrations) in untreated infarcted rats. Chronic captopril treatment resulted in a significantly improved inotropic response to isoproterenol (p<0.05 compared with muscles from untreated infarcted rats). The lack of inotropic response in the muscles from infarcted rats occurred despite a large increase in the peak amplitude of the Ca2+' transient determined from the aequorin signal. Representative experimental recordings of isometric twitches and aequorin light signals from a sham-operated rat and an untreated infarcted rat are shown in Figure 3 Isoproterenol (log M) FIGURE 2. Inotropic response to isoproterenol in papillary muscles from sham-operated (n=13), untreated infarcted (MI, n=14), and captopril-treated infarcted (MI Capto, n=14) rats plotted as peak rate of tension rise (dT/dt) vs. isoproterenol concentration. Peak rate oftension rise increases significantly in response to isoproterenol in muscles from the sham-operated rats but changes very little in the MI rats (*p<0.05 for sham-operated vs. MI rats). The inotropic response to isoproterenol in muscles from the MI Capto rats was significantly greater than that of the MI rats at an isoproterenol concentration of 10 6 M (#p <O.05 for MI Capto vs. MI rats). Data are shown as mean +SEM.
increase in developed tension. The mean change in the amplitude of the aequorin light signal during isoproterenol stimulation for each of the three groups is shown in Figure 4 . Although Ca'i, availability increased in all groups, the percent change was significantly greater in the muscles from the sham-operated rats than in either of the infarcted groups. Despite the blunted inotropic response to isoproterenol in the muscles from the infarcted rats, muscles from all three groups exhibited shortening of the time course of isometric contraction and relaxation during ,B-adrenergic receptor stimulation ( Figure 5 ). The enhancement of myocardial relaxation is referred to as a positive lusitropic effect. '4 To assess the relation between LV loading conditions in vivo and inotropic reserve of noninfarcted myocardium, we plotted the increase in dT/dt (as percentage of baseline) at maximal isoproterenol stimulation versus the LV end-diastolic pressure recorded in vivo in each rat (Figure 6 ). There was a highly significant (r= -0.64, p<0.0001) inverse relation between these variables. This was particularly evident in the captopril-treated infarcted rats in which there was a wide range of LV filling pressures (8-33 mm Hg). The rats with the lowest LV end-diastolic pressures during captopril treatment had the greatest inotropic responsiveness to f3-adrenoceptor stimulation.
Finally, because peak [Ca2]i-peak force relations in actively twitching muscles may not accurately reflect myofilament responsiveness to Ca'+, force-[Ca2`]i relations were recorded during tetani. An example of these recordings is shown in Figure 7 . Mean values for tetanic force and [Ca2"]i at each [Ca2']0 for all three groups of rats are shown in Figure 8 . The force-[Ca'+]i points for muscles from all three groups of rats lie along a common line (r=0.966, p<0.001), suggesting that myofilament sensitivity to Ca'+ is unchanged.
Discussion
Our data show that noninfarcted myocardium is characterized by abnormalities of Ca'+i handling, suggesting sarcoplasmic reticular dysfunction, and impaired contractility, suggesting myofilament abnormalities. In addition, f3-adrenoceptor stimulation in failing myocardial tissue resulted in increased Ca'i, availability and enhanced myocardial relaxation as expected; however, the inotropic response to 13-adrenoceptor stimulation was severely blunted. These findings suggest an alteration in ,B-adrenergic receptor signal transduction distal to the activation of the cAMP-dependent enzyme, protein kinase A, probably at the level of the myofilaments. Chronic treatment with captopril after myocardial infarction improved baseline Ca2'i handling and contractility and resulted in partial restoration of the inotropic response to isoproterenol. The magnitude of the inotropic response to ,B-adrenoceptor stimulation correlated with the amount of hemodynamic improvement achieved during captopril treatment in each rat.
Finally, force-Ca'+i relations measured during tetanic contractions indicate that myofilament responsiveness to Ca2' is not changed in noninfarcted myocardium.
Thus, the major defect in contractility of surviving myocardium after infarction appears to be a reduction in maximal force-generating capacity.
Mechanisms of Depressed Contractility in Noninfarcted Myocardium
Our findings of prolongation of the time courses of the calcium transients and the isometric twitches are consistent with those in several other animal models of cardiac hypertrophy and failure. 15, 16 The changes in the speed of contraction may be related, in part, to alterations in the isomyosin composition of the tissue. Increases in the percentage of the "slow activity" V3 myosin isoform have been shown to occur in the noninfarcted myocardium in this model of heart failure.11,17 However, this alteration of the isomyosin profile probably would not account for the alterations in the time course of the Ca'+i transient or for the depression of maximal force-generating capacity in twitching or tetanized muscles. The prolongation of the Ca'+i transient suggests that there are abnormalities of release and reuptake of Ca2' by the sarcoplasmic reticulum function in the surviving myocardium. This is compatible with previous reports that there is decreased expression of sarcoplasmic reticular Ca2'-ATPase in hypertrophied rat hearts.18 A decreased rate of release of Ca2' from the sarcoplasmic reticulum might explain an increase in the time to peak tension or a reduction in dT/dt. However, peak Ca 2+ availability does not seem to be depressed in the failing myocytes and, therefore, cannot be invoked as a cause of decreased peak tension development under the base- The muscle from the sham-operated rat showed parallel increases in developed tension and peak light, as well as abbreviation of the time course of contraction and relaxation in response to isoproterenol. In contrast, the muscle from the MI rat exhibited progressive decreases in developed tension despite an increase in the peak light. At the higher isoproterenol concentrations, the muscle from the MI rat developed prominent "afterglimmers" and "aftercontractions" (arrow) that are believed to be due to spontaneous release of Ca 2+ from the sarcoplasmic reticulum.
line conditions of our experiments. Failure to adequately augment Ca2'i availability may contribute to the impaired inotropic response seen during /3-adrenoceptor stimulation or the lower tetanic force seen in the muscles from infarcted rats. The "afterglimmers" and corresponding "aftercontractions" that appeared during isoproterenol stimulation of the failing myocardium ( Figure 3 ) are thought to be due to spontaneous release of Ca2' from the sarcoplasmic reticulum.19 These findings provide further evidence of sarcoplasmic reticular dysfunction in the noninfarcted myocardium. Another possible cause of depressed contractility in the noninfarcted myocardium is an alteration in the extracellular matrix of the heart, such as increased interstitial fibrosis.20 An increase in extracellular collagen might lower the number of sarcomeres per unit of tissue cross-sectional area or could exert a tethering effect on the contractile apparatus. Changes in the interstitium could also adversely affect the availability of oxygen or metabolic substrates to the myocytes. We have previously reported increased hydroxyproline content of noninfarcted myocardium in this model of heart failure.10 However, the relatively modest elevation of tissue collagen content is probably not the sole explanation for the markedly impaired force development observed in these muscles.
Finally, it is possible that there is a decrease in the calcium responsiveness of the myofilaments in the noninfarcted myocardium. A change in "calcium responsiveness," as used herein, could include both changes in ECS, and changes in the maximal effect.15 A decrease in myofilament responsiveness to Ca2' is suggested by the observation that developed tension was lower in isometrically contracting muscles from infarcted rats compared with control rats, even at maximally activating [Ca`2+Is. Furthermore, Ca2'i availability was comparable in twitching muscles from both groups of rats (Table   3 ). The downward shift of the force-[Ca2`]o curve in the muscles from rats with large myocardial infarctions is suggestive of a decrease in the maximal effect of calcium. Similarly, maximal force generation in muscles from rats with large myocardial infarctions also showed a trend toward being decreased during tetani elicited at [Ca2']0 of 8.0 mM (Figure 8 ). However, Ca2'i availability was also lower during tetani in the muscles from the infarcted rats compared with sham-operated rats. The force-Ca i points for muscles from all three groups of rats appear to lie along the same line (Figure 8 ). This suggests that the affinity of troponin C for Ca2' is not altered in the setting of postinfarction heart failure. Our findings are compatible with a previous study measuring Ca2' sensitivity in chemically skinned cardiac fibers from spontaneously hypertensive rats with evidence of heart failure. 21 In that study there was no change in the [Ca2] required to produce 50% maximal activation of the myofilaments in aged spontaneously hypertensive rats compared with age-matched Wistar-Kyoto rats. Thus, the results of studies in both twitching and tetanized papillary muscles suggest to us that the depressed contractility in noninfareted myocardium is primarily attributable to decreased maximal force-generating capacity. This may be due to decreased numbers Isoproterenol log (M) FIGURE 4. Graph showing that the amplitude of the aequorin light signal increased in response to increasing concentrations of isoproterenol in sham-operated rats (n=13), untreated rats with myocardial infarction (MI rats, n=14), and captopril-treated rats with myocardial infarction (MI captopril rats, n=14). This suggests that myocytes from all three groups ofrats have at leastpartially intact 83-adrenergic signal transduction. There was a greater increase in peak light (shown as percent change from baseline) in the shamoperated than in the MI or MI captopril rats. The downward shift of the peak light vs. isoproterenol concentration curves in the muscles from the infarcted rats is consistent with decreased 3-adrenergic receptor density or uncoupling of the receptor from the intracellular second messengers. Data are mean ± SEM. *p<0. 05 for MI vs. sham-operated rats. of actin-myosin crossbridges, decreased strength of individual crossbridges, or extramyocyte factors such as interstitial fibrosis.
Abnormalities of /3-Adrenoceptor Signal Transduction in Noninfarcted Myocardium
p-Adrenergic receptor stimulation of the heart causes an increase in intracellular cAMP. This affects the time course and amplitude of subsequent cardiac contractions via the actions of the cAMP-dependent enzyme protein kinase A. 22 The net result of phosphorylation at several intracellular sites in normal myocardium is an increase in developed tension and in peak rate of tension rise and fall and a decrease in the time to peak tension and in relaxation time.
Exposure of the noninfarcted papillary muscles to the P-adrenergic receptor agonist isoproterenol resulted in the expected changes in the amplitude of the calcium transient and the time course of the isometric twitch. The abbreviation of the relaxation half-time during 8-adrenergic stimulation implies that sarcoplasmic reticular Ca24 uptake was stimulated via the phosphorylation of phospholamban.22 This suggests that some elements of the ,B-adrenergic receptor signal transduction pathway are intact. However, even though the amplitude of the calcium transient increased, dT/dt did not increase, and developed tension fell in the muscles from the infarcted rats. One possible explanation for these observations is that the expected "desensitiza-tion" of myofilaments that occurs after ,B-adrenergic receptor stimulation19'23 is exaggerated in the infarcted rats. Such a change might reflect structural alterations in the regulatory proteins. It is possible that shifts in the expression of different troponin isoforms could cause this type of phenomenon. 24 The dissociation of inotropic and lusitropic responses after catecholamine exposure in failing myocardium in vitro are analogous to the effects of catecholamines in patients with heart failure and in the aged rodent heart.25-27 However, a decrease in force development, as seen in the present study, was not seen in otherwise normal aged myocardium. It has previously been observed that saturation of the inotropic response to increasing Ca2 i correlates with the appearance of spontaneous oscillatory Ca2' release from the sarcoplasmic reticulum.28 Theoretically, diastolic Ca2' release from the sarcoplasmic reticulum could limit force production by decreasing Ca2' release during the subsequent stimulated contraction. Although the development of afterglimmers and aftercontractions during isoproterenol administration in the muscles from infarcted rats appears to be similar to the spontaneous Ca2' oscillations described by Capogrossi et al,28 we found that peak systolic [Ca24]i continued to increase as isoproterenol concentration was increased (Figures 3 and 6 ). Thus, decreased availability of activator Ca 2+ cannot be the cause of the decline in force production in the failing muscles. Furthermore, during isoproterenol stimulation of the muscles from infarcted rats, developed tension began to decline even before the appearance of afterglimmers and aftercontractions (Figure 3 ). Finally, careful inspection of the calibrated light and tension signals shown in Figure 3 reveals that diastolic [Ca 21]i and diastolic tension decrease at higher concentrations of isoproterenol, even in the presence of the spontaneous Ca2+ release. Therefore, we speculate that ,B-adrenergic stimulation produces an exaggerated decrease in myofilament sensitivity to Ca24 in the failing tissues. These findings may partially explain the cellular basis for the dissociation of lusitropic and inotropic effects of P-adrenergic stimulation in patients with heart failure.25
Effects of Captopril on Intracellular Calcium Handling and /3-Adrenergic Receptor Function After Myocardial Infarction
Captopril treatment has previously been shown to improve hemodynamics and survival in the rat infarct model of heart failure. 8, 9, 29 We found that captopril lowered mean arterial pressure in all treated rats; however, there was a wide range in the LV filling pressures in this group (8-33 mm Hg). This is consistent with previous reports of variable and time-dependent responses to ACE inhibitors in patients with heart failure. 30 The rats that had the greatest decrease in LV filling pressures had the greatest positive inotropic response to ,B-adrenergic receptor stimulation. These findings suggest that chronic elevations of LV wall stress may directly mediate biochemical changes in the myocytes. Therefore, simple load reduction may explain the improvement in maximal force production seen in the captopril-treated infarcted rats.
The beneficial hemodynamic effects, in concert with a purported sympatholytic effect of ACE inhibition,31 may have restored inotropic responsiveness to f3-adrenergic Isoproterenol log (M) FIGURE 5 . The time course of the isometric twitch, shown as time to peak tension and halftime to relaxation, isprolonged under baseline conditions in muscles from untreated rats with large myocardial infarction (MI rats) (*p<0.05 for MI vs. sham-operated rats). Time to peak tension and half time to relaxation shorten as expected during a graded concentration-response reaction to isoproterenol in sham-operated rats (n=13), MI rats (n=14), and captopril-treated rats with myocardial infarction (MI Capto rats, n=14). This suggests that phosphorylation of troponin I and phospholamban by cAMP-dependent protein kinases has occurred. Data are mean +SEM. Statistical comparisons of MI Capto vs. sham-operated rats are not shown.
receptor stimulation. The lack of a reflex increase in heart rate in the captopril-treated infarcted rats, despite a fall in mean arterial pressure, is consistent with a withdrawal of sympathetic activation. Because chronic exposure to catecholamines' or angiotensin 1132 may cause myocyte death, replacement fibrosis, and ,8-adrenoceptor downregulation in the heart, reduction in serum or tissue, norepinephrine, and angiotensin II levels could also explain an improved inotropic responsiveness to isoproterenol. The results of the present study do not allow us to clearly distinguish if the beneficial effects of ACE inhibition are related to load reduction, withdrawal of pathological neurohumoral activation, or both. However, it is clear that treatment with ACE inhibitors may result in improved function at the cellular level, in addition to beneficial effects on global cardiac function.
Relation to Previous Studies
We have previously shown that noninfarcted myocardium from rats with large infarctions exhibits contractile dysfunction and increased passive stiffness.10 Our present results confirm those of the earlier study; however, in the previous study, 3 weeks of captopril treatment resulted in no improvement of force development in isolated papillary muscles. In the current study, treatment was begun earlier after myocardial infarction (1 week versus 3 weeks) and continued longer (5 weeks versus 3 weeks). The longer duration of treatment may explain why papillary muscles from captopril-treated infarcted rats had partial normalization of force development in the present study.
The present results expand on those of the previous study by showing that there are alterations in Ca + regulation in the noninfarcted myocardium that could contribute to contractile dysfunction. These data are similar to findings in senescent spontaneously hypertensive rats with evidence of heart failure. 16 We also show for the first time that chronic ACE inhibition may partially restore the positive inotropic response to 8-adrenergic receptor stimulation in noninfarcted myocar- LV end-diastolic pressure (mmHg) FIGURE 6. Left ventricular (LV) end-diastolic pressure measured in vivo plotted against maximal inotropic response during isoproterenol stimulation (percent change in +dT/dt from baseline) in isolated papillary muscles from shamoperated, captopril-treated infarcted (MI Capto), and infarcted (MI) rats. There is an inverse relation between LV end-diastolic pressure and inotropic response to isoproterenol (r= -0.64, p<0.0001) for all groups, suggesting that in vivo loading conditions may directly mediate the biochemical changes that develop in the noninfarcted myocardium. dium. Our findings are consistent with reports that captopril treatment in rats with isoproterenol-induced cardiac hypertrophy results in upregulation of cardiac 3-adrenergic receptors.3 Furthermore, ACE inhibition in patients with heart failure has been associated with increases in lymphocyte f-adrenergic receptor density.4
Our results are partially consistent with a previous report showing that right ventricular contractility, inotropic responsiveness to isoproterenol, and -3adrenoceptor density were all decreased 3 days after myocardial infarction in guinea pigs.32 In that study, the abnormal right ventricular responsiveness to isoproterenol had resolved by 7 days after infarction. It is difficult to compare the findings of Baumann et al33 with our findings because of differences in the model studied, a much shorter duration of follow up, and lack of evidence of heart failure in the previous study. Our findings differ from those of the only other published report of f3-adrenergic influences on contractility in the rat infarct model of heart failure (Felenius et al34). In that study the j3-adrenoceptor agonist prenalterol was found to cause a proportionally greater increase in ventricular function in hearts from infarcted rats than in sham-operated rats. However, the aforementioned study was done only 1 week after infarction, a time when the degree and duration of sympathetic activation may have been too limited to cause overt dysfunction of the f3-adrenergic pathway.
Limitations of This Study
Various changes in the p-adrenergic pathway at the level of the receptor itself, the G proteins, and the adenylate cyclase complex have been described in humans and experimental models of heart failure.' It is not possi- The force-Ca 2+i points for muscles from all three groups of rats appear to lie along the same line. Thus, myofilament sensitivity to Ca 2+ does not appear to be altered in the noninfarcted myocardium. There is a trend toward decreased maximal tetanic force development in the muscles from MI rats.
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.I ble from our data to determine the precise location of the defect in the 83-adrenergic pathway in the noninfarcted myocardium of the rat. Our findings suggest alterations at the level of the myofilaments; however, this will require biochemical confirmation. In addition, we cannot determine whether the beneficial effects that accrued in the captopril-treated rats were related to changes in loading conditions, reduction of sympathetic activation, or both. The parallel appearance of changes in Ca 2+i handling and contractility in untreated infarcted rats and the coordinate resolution of these changes after captopril treatment implies, but does not prove, a causal relation.
Conclusions
Our data show for the first time that abnormalities of Ca2'i handling may contribute to impaired contractility in noninfarcted myocardium. In addition, abnormalities of myofilament Ca2' responsiveness may contribute to diminished force development, especially during f3-adrenergic stimulation. The contractile dysfunction in this model of heart failure seems to be primarily related to a decrease in maximal forcegenerating capacity without evidence for a change in myofilament sensitivity to Ca2`. Improvement of LV loading conditions and/or reduction of sympathetic activation with the ACE inhibitor captopril may result in improvement of contractility, Ca2'i handling, and inotropic responsiveness to P-adrenergic receptor stimulation in noninfarcted myocardium. Because some captopril-treated rats had little improvement of LV function or /3-adrenergic responsiveness, it appears that loss of a critical mass of myocardium may result in irreversible myocardial dysfunction, despite maximal unloading therapy.
